Cargando…

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment

Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clari...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Xiao, Weiping, Zhang, Qing, Xia, Ding, Gao, Peng, Su, Jiabin, Yang, Heng, Gao, Xinjie, Ni, Wei, Lei, Yu, Gu, Yuxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413783/
https://www.ncbi.nlm.nih.gov/pubmed/34279201
http://dx.doi.org/10.2174/1570159X19666210716114016
_version_ 1784775834829062144
author Zhang, Xin
Xiao, Weiping
Zhang, Qing
Xia, Ding
Gao, Peng
Su, Jiabin
Yang, Heng
Gao, Xinjie
Ni, Wei
Lei, Yu
Gu, Yuxiang
author_facet Zhang, Xin
Xiao, Weiping
Zhang, Qing
Xia, Ding
Gao, Peng
Su, Jiabin
Yang, Heng
Gao, Xinjie
Ni, Wei
Lei, Yu
Gu, Yuxiang
author_sort Zhang, Xin
collection PubMed
description Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of neuroimaging techniques, various neuroimaging modalities with different advantages have deepened the understanding of MMD in terms of structural, functional, spatial, and temporal dimensions. At present, the main treatment for MMD focuses on neurological protection, cerebral blood flow reconstruction, and neurological rehabilitation, such as pharmacological treatment, surgical revascularization, and cognitive rehabilitation. In this review, we discuss recent progress in understanding the clinical features, in the neuroimaging evaluation and treatment of MMD.
format Online
Article
Text
id pubmed-9413783
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-94137832022-10-04 Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment Zhang, Xin Xiao, Weiping Zhang, Qing Xia, Ding Gao, Peng Su, Jiabin Yang, Heng Gao, Xinjie Ni, Wei Lei, Yu Gu, Yuxiang Curr Neuropharmacol Neurology Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of neuroimaging techniques, various neuroimaging modalities with different advantages have deepened the understanding of MMD in terms of structural, functional, spatial, and temporal dimensions. At present, the main treatment for MMD focuses on neurological protection, cerebral blood flow reconstruction, and neurological rehabilitation, such as pharmacological treatment, surgical revascularization, and cognitive rehabilitation. In this review, we discuss recent progress in understanding the clinical features, in the neuroimaging evaluation and treatment of MMD. Bentham Science Publishers 2022-02-17 2022-02-17 /pmc/articles/PMC9413783/ /pubmed/34279201 http://dx.doi.org/10.2174/1570159X19666210716114016 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Neurology
Zhang, Xin
Xiao, Weiping
Zhang, Qing
Xia, Ding
Gao, Peng
Su, Jiabin
Yang, Heng
Gao, Xinjie
Ni, Wei
Lei, Yu
Gu, Yuxiang
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
title Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
title_full Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
title_fullStr Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
title_full_unstemmed Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
title_short Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
title_sort progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413783/
https://www.ncbi.nlm.nih.gov/pubmed/34279201
http://dx.doi.org/10.2174/1570159X19666210716114016
work_keys_str_mv AT zhangxin progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT xiaoweiping progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT zhangqing progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT xiading progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT gaopeng progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT sujiabin progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT yangheng progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT gaoxinjie progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT niwei progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT leiyu progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment
AT guyuxiang progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment